Contribution of free fatty acids to impairment of insulin secretion and action. Mechanism of β-cell lipotoxicity;Rôle des acides gras libres dans la sécrétion et l'action de l'insuline: Mécanismes de la lipotoxicité

Medecine/Sciences

Volumn 19, Issue 8-9, 2003, Pages 827-833

  Girard, Jean ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCAGON; INSULIN; LONG CHAIN FATTY ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

APOPTOSIS; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE TRANSPORT SYSTEM; HORMONAL REGULATION; HORMONE ACTION; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN;

EID: 0141650781     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20031989827     Document Type: Review

References (35)

1. Owen OE, Reichard GA, Patel MS, Boden G. Energy metabolism in feasting and fasting. In: Klachko DM, Anderson RR, Heimberg M, eds. Hormone and energy metabolism. New York: Plenum Press, 1979: 169-88.
2. Reaven GM, Hollenbeck CB, Jen CY, Wu MS, Chen YDI. Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 1988; 37: 1020-4.
3. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.
4. Randle PJ, Kerbey AL, Espinal J. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes Metab Rev 1988; 4: 623-8.
5. Zierler KL. Fatty acids as substrates for heart and skeletal muscle. Circ Res 1976; 39: 459-63.
6. Girard J. Rôle des acides gras libres dans l'insulino-ré sistance au cours du diabète non-insulino-dépendant. Diabete Metab 1995; 21: 79-88.
7. Boden G. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci 2003; 72: 977-88.
8. Girard J. Acides gras, insulinosécrétion et lipotoxicité. Med Ther Endocrinol 2000; 2 (suppl2): 29-36.
9. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 1995; 44: 863-70.
10. Unger RH, The physiology of cellular liporegulation. Annu Rev Physiol 2003; 65: 333-47.
11. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171-6.
12. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alteratiors in the insulin signaling cascade. Diabetes 1999; 48: 1270-4.
13. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humors. J Clin Invest 1996; 97: 2859-2865.
14. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidy linositol 3-kinase activity. J Clin Invest 1999; 103: 253-9.
15. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 2000; 275: 8456-60.
16. Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105: 271-8.
17. Berne C. The metabolism of lipids in mouse pancreatic islets: the oxidation of fatty acids and ketone bodies. Biochem J 1975; 152: 661-6.
18. Malaisse WJ, Malaisse-Lagae F, Sener A, Hellerström C. Participation of endogenous fatty acids in the secretory activity of the pancreatic β-cell. Biochem J 1985; 227: 995-1002.
19. Grupping AY, Cnop M, Van Schravendijk C, Hannaert J, Van Berkel T, Pipeleers D. Low density lipoprotein binding and uptake by human and rat islet β-cells. Endocrinology 1997; 138: 4064-8.
20. Stein DT, Esser V, Stevenson BE, et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 1996; 97: 2728-35.
21. Mason TM, Goh T, Tchipashvili V, et al. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 1999; 48: 524-30.
22. Paolisso G, Gambardella A, Amato L, et al. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995; 39: 1295-9.
23. Prentki M, Joly E, El-Assaad W, Roduit R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 2002; 51 (suppl 3): S405-13.
24. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992; 258: 766-70.
25. McGarry JD, Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7-18.
26. Unger RH. How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 1997; 8: 276-82.
27. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999; 42: 128-38.
28. Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998; 47: 358-64.
29. Man ZW, Zhu M, Noma Y, et al. Impaired β-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes 1997; 46: 1718-24.
30. Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-36.
31. Unger RH, Zhou YT, Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA 1999; 96: 2327-32.
32. Shimabukuro M, Zhou YT, Lee Y, Unger RH. Troglitazone lowers islet fat and restores β-cell function of Zucker diabetic fatty rats. J Biol Chem 1998; 273: 3547-50.
33. Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH. Troglitazone prevents mitochondrial alterations, β-cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 1999; 96: 11513-8.
34. Marshak S, Leibowitz G, Bertuzzi F, et al. Impaired β-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 1999; 48: 1230-6.
35. Poitout V, Robertson RP. Secondary β-cell failure in type 2 diabetes. A convergence of glucatoxicity and lipotoxicity. Endocrinology 2002; 143: 339-42.